Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2011-04-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. the respiratory function decline by means of spirometry and the respiratory health by means of questionnaire and six-minute walking distance
2. the presence of markers of early atherosclerosis with ultrasound and to estimate the value of systolic pulmonary pressure in comparison with not exposed subjects.
The investigators hypothesize that the chronic exposure to indoor pollution
1. can accelerate the physiological respiratory function decline, usually around 15-20mL/year in healthy subjects
2. induce cardiovascular impairment
The population of high altitude villages is a unique sample to study the effect of the only indoor pollution. In fact, the absence of traffic, due to the lack of roads, and the very low level of smoking habits allow to have no other confounding factors
3. to study and analyze how the architectural features of the buildings of the village (distribution of domestic locals, natural or non natural ventilation systems, domestic activities, materials used, etc.) affect the indoor pollution from carbon monoxide, which necessarily is developed indoor during the daily life activities.
What the project prospects is to gather information focused on the scale of the building, independently from the typology, to study a model that will help to describe which aspects are most important to what concern the genesis of the pollution of the indoor air.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Air Pollution on Chronic Respiratory Diseases
NCT03813810
Short- and Long-term Health Effects of Air Pollution in Poland
NCT05198492
Cardiovascular Vulnerability to Particulate Exposure
NCT00013949
Air Pollution and Cardio-metabolic Health
NCT04125212
Air Pollution and Cardiometabolic Study
NCT02601352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
14 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
OTHER_GOV
Università degli Studi di Ferrara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Ferrara
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annalisa Cogo, MD
Role: STUDY_DIRECTOR
University of Ferrara, Italy
Lorenza Pratali, MD
Role: PRINCIPAL_INVESTIGATOR
Institute of Clinical Physiology National Council of Research, Pisa, Italy
Luca Pomidori, PhD
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi di Ferrara
Sanjay Nath Khanal, MD
Role: PRINCIPAL_INVESTIGATOR
Kathmandu University
Enrico Duo
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi di Ferrara
Maria Rosa Bruno, MD
Role: PRINCIPAL_INVESTIGATOR
Institute of Clinical Physiology National Council of Research, Pisa, Italy
Chan Bahadur Thapa, MD
Role: PRINCIPAL_INVESTIGATOR
Tribhuvan University Institute of Medicine (Nepal)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Clinical and Experimental Medicine- section of Respiratory Disease-University of Ferrara
Ferrara, Ferrara, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HA indoor/pollution
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.